Kronisk bihulebetændelse og type 2-sygdom
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 550 KB, PDF document
Diseases of the upper and lower airways are commonly described as global airway disease, which shares basic inflammatory mechanisms, and airway comobidity is frequently found. The prevalence of chronic rhinosinusitis (CRS) is 5-12%, characterised as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). Inflammation in CRSwNP is often type 2, whereas CRSsNP often involves non-type 2. New monoclonal antibodies towards type-2 inflammation have been launched internationally to treat refractory severe CRSwNP, with effect on polyps, congestions and smell, as well as quality of life. This review gives a summary of the current treatment modalities.
Translated title of the contribution | Chronic rhinosinusitisand type 2 disease |
---|---|
Original language | Danish |
Article number | V05210446 |
Journal | Ugeskrift for Laeger |
Volume | 184 |
Issue number | 10 |
Number of pages | 9 |
ISSN | 0041-5782 |
Publication status | Published - 7 Mar 2022 |
Links
ID: 329209300